There are no FDA-approved therapies for this age group, although, Wegovy has been cleared since 2022 for use in children and adolescents aged 12 and over, and Saxenda for the same age range since ...

Saxenda is another GLP-1 receptor agonist FDA approved for weight management in adults with obesity and adults with overweight and weight-related medical concerns. It’s also approved for use in ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

Find out all you need to know about Ozempic and other weight loss drugs, including the dangers and side effects ...

Alexandra Sowa's new book The Ozempic Revolution is intended to be the "first comprehensive user guide" to GLP-1 drugs like ...

Danish pharmaceutical giant Novo Nordisk A/S (NYSE:NVO) submitted a Citizen Petition to the FDA requesting the exclusion of liraglutide from the 503B Bulks List, a registry of substances that ...

It's not just celebrities and TikTok creators jumping on the weight loss drug hype - more than 500,000 people in the UK are ...

Weight-loss drugs are transforming health care and Wall Street, but exciting prospects don’t necessarily mean a company is a good investment.

GLP-1 agonists for weight loss are now commonly used for adults, but might they also be an effective treatment for younger ...

A new study conducted by researchers from the University of Eastern Finland the Karolinska Institutet explored the ways that ...

Losing weight can feel like climbing a mountain with no clear path. The one-size-fits-all advice—like “eat less, move ...